Medtech firm plans clinical trials following €6.7 million investment | Business Post

  • 📰 businessposthq
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 71%

Portugal Notícia Notícia

Portugal Últimas Notícias,Portugal Manchetes

Medtech Versono’s Fastwire intravascular device is designed to allow doctors get through the most difficult blockages they find in arteries, emmetjryan reports.

Finbar Dolan, chief executive, Versono: ‘The investment means we’ll be able to get the product out in front of a large community of doctors and start that process of commercialisation’

Versono, a medical devices company based in Galway, plans to have the first two clinical trials of its intravascular device completed by the end of next year.“The investment allows us to go ahead with our clinical trials. It means we’ll be able to get the product out in front of a large community of doctors and start that...

 

Obrigado pelo seu comentário. Seu comentário será publicado após ser revisado.
Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

 /  🏆 8. in PT

Portugal Últimas Notícias, Portugal Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Chinese investor claims cash-for-visa firm no longer operating in Ireland | Business PostZhiming Xi, who invested €1m through the Immigrant Investor Programme, is suing the Huawen Foundation after it failed to respond to his concerns
Fonte: businessposthq - 🏆 8. / 71 Consulte Mais informação »

Stripe’s valuation upgraded as firm looks to learn from Plaid ‘kerfuffle’ | Business PostFidelity Investments has marked up the value of its stake in Stripe, the online payments company, having downgraded it earlier this year.
Fonte: businessposthq - 🏆 8. / 71 Consulte Mais informação »

Dept of Health reviewing HSE’s business case for relocation of NMH | Business PostThe HSE’s business case for the controversial relocation of the National Maternity Hospital is undergoing a technical review by the Department of Health as part of new rules to stop a repeat of the National Children’s Hospital budget’s overrun.
Fonte: businessposthq - 🏆 8. / 71 Consulte Mais informação »